Investor Presentaiton

Group Adjusted EBITDA Reconciliation In IDR Billions, unless otherwise stated Loss before income tax Add/(Deduct): Depreciation and amortization expenses Finance income Interest expenses EBITDA goto 2Q 2023 For The Three Months Ended June 30, For The Six Months Ended June 30, 2023 2022 2023 2022 (3,322) (7,559) (7,457) (14,185) 673 778 1,379 1,539 (147) (212) (310) (332) 87 54 (2,709) (6,939) 157 (6,231) 95 (12,883) Unrealized foreign exchange loss/(gain) from cash remeasurement 19 (305) 271 (386) Share of net losses in associates and joint ventures 113 143 185 219 Loss/(gain) on divestment and dilution of investment in associates and joint ventures, net 145 5 145 (34) Loss on impairment of investment in associates and joint ventures 218 288 230 288 Loss on impairment of intangible and fixed assets 1 Fair value adjustment of financial instruments 792 (303) 683 (1,359) Share based compensation cost 125 2,264 1,693 4,391 Dividend income Non-recurring items' Adjusted EBITDA (15) (24) (15) (24) 104 548 233 606 (1,208) (4,323) (2,805) (9,182) Note: 1. These non-recurring items also include share based compensation costs - Gotong Royong Program and restructuring costs 25

View entire presentation